We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Idebenone
A synthetic short-chain analog of coenzyme Q10 designed to support mitochondrial electron transport and act as an antioxidant. Important context: it has almost entirely been studied as a prescription DRUG (approved for Leber hereditary optic neuropathy in the EU as Raxone), not as an OTC supplement — and even its drug trials are mixed, with several outright negative neurological endpoints.
What the evidence says
Most Idebenone studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from medium-quality randomised trials published 1998–2011 with a typical study size of 85 participants.
Based on 4 studies · 4 RCTs · 675 total participants
Confidence
ModerateBy outcome
Idebenone has an evidence score of 3/10 — emerging evidence based on 4 indexed studies. A synthetic short-chain analog of coenzyme Q10 designed to support mitochondrial electron transport and act as an antioxidant. Important context: it has almost entirely been studied as a prescription DRUG (approved for Leber hereditary optic neuropathy in the EU as Raxone), not as an OTC supplement — and even its drug trials are mixed, with several outright negative neurological endpoints. Representative study: PMID 21788663.
The commonly studied dose of Idebenone is Drug trials used 900mg/day (LHON) up to ~2250mg/day (ataxia); no validated OTC supplement dose. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Explore: Best supplements for Focus, Memory & MoodBest supplements for Body Health
Last reviewed June 2026 · evidence from 4 studies · how we score
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Idebenone is a synthetic, shorter-tailed analog of coenzyme Q10 that can shuttle electrons in the mitochondrial respiratory chain and scavenge free radicals, with the theoretical advantage of better water solubility and brain penetration than CoQ10. Crucially, idebenone has been developed and studied primarily as a pharmaceutical, not a dietary supplement: it is approved in the EU (as Raxone) for Leber hereditary optic neuropathy (LHON), a mitochondrial cause of vision loss. The evidence base is genuinely mixed. In LHON, the pivotal RHODOS randomized trial missed its primary visual-acuity endpoint, with benefit appearing only in a post-hoc subgroup of patients with discordant baseline vision. In Friedreich ataxia, multiple randomized placebo-controlled trials found NO significant benefit on neurological function or cardiomyopathy. Older Alzheimer's-disease studies suggested modest cognitive benefit, but a later large US trial was negative. So while the mitochondrial rationale is real, idebenone should be understood as a drug with mixed-to-null results on most endpoints — not a well-validated cognitive or vision supplement.
As a CoQ10 analog, idebenone can transfer electrons in the respiratory chain, theoretically supporting ATP production in dysfunctional mitochondria.
Scavenges free radicals and may reduce lipid peroxidation, with relatively good water solubility and CNS penetration versus CoQ10.
How Idebenone works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Tap node to isolate • Pinch to zoom • Tap edge for research
Drug trials used 900mg/day (LHON) up to ~2250mg/day (ataxia); no validated OTC supplement dose
Take with food
| Form | Type |
|---|---|
| 💊Idebenone | Recommended |
| 💊Coenzyme Q10 (ubiquinone/ubiquinol) | Alternative |
For general mitochondrial/antioxidant support, CoQ10 is the better-studied OTC option; idebenone's data are drug-context.
Minimum: 12 weeks
Optimal: 24 weeks
Cycling: Not required
Note: With fat-containing meals; pharmaceutical use is divided across the day.
Dose-response data unavailable. The current published research for Idebenone does not provide sufficient dose-specific outcome data to generate reliable dose-response curves.
Refer to the Dosage & Timing section above for recommended dose ranges based on available evidence.
Modest, inconsistent visual-acuity benefit in Leber hereditary optic neuropathy; primary endpoint not met in the pivotal RCT.
Randomized trials found no significant effect on neurological function or cardiomyopathy.
Evidence comes from pharmaceutical trials at high doses; OTC supplement efficacy is unestablished.
Use only under specialist/neuro-ophthalmology care — this is a prescription indication.
Not adequately studied — avoid.
Idebenone is metabolized via CYP3A4; strong inhibitors/inducers could alter its levels. Discuss with a clinician.
As with CoQ10-type compounds, theoretical interaction with anticoagulant control; monitor if combined.
Tip: Take with food
Tip: Harmless; expected with the compound
Tip: Reduce dose
Idebenone is a synthetic CoQ10 analog; the two target the same mitochondrial electron-transport rationale. CoQ10 has the broader OTC evidence base.
Overlapping mitochondrial-support rationale — generally redundant rather than additive.
Both are marketed for mitochondrial/bioenergetic support via different pathways (electron transport vs fatty-acid transport).
Layered mitochondrial-support rationale (both modestly evidenced).
The best time to take Idebenone is with meals. Take it with food. Absorption improves with food (fat); pharmaceutical regimens divide the dose across meals.
Idebenone is generally safe at recommended doses, with a few precautions worth noting. The most commonly reported side effects are mild GI upset (nausea, diarrhea), reddish/orange discoloration of urine, headache. Use caution if any of these apply to you: Pregnancy/breastfeeding (not adequately studied); Known hypersensitivity to idebenone.
Enhances mitochondrial energy production and acts as a lipid-soluble antioxidant — critical for heart health and depleted by statins.